was added for 10 min to eliminate the activity of endogenous peroxidase. The sections were applied with drops of ready-touse primary antibody, stored in a refrigerator for 4 ℃ overnight, applied with secondary antibody (PV9000 Immuno-Bridge; GBI Company, USA), and placed in a water bath at 37 ℃ for 30 min. The sections were then colored with freshly prepared diaminobenzidine. PBS was used instead of primary antibody as a negative control. Several organizations, which have positive antibody proteins, were employed as positive control.
Determination of results: The positive expression of substance was brown. The expression site of CD20, CD79a, CD5, CD21, CD23, and CD10 was the membrane and that of Pax5, cyclin Dl, TdT, and Ki-67 was the nucleus. Cell membrane and cytoplasm were the expression sites of CD3.
Fluorescence in situ hybridization (FISH) detection
IgH/CCND1 Probe was purchased from Vysis (USA). Hybridization step was carried out following the method provided in www.vysis.com (Vysis). Results were observed under a fluorescence microscope with reactive lymphoid tissue as normal control.
IgH probe of green fluorescence hybridization with two target fragments of IgH on 14q32 was marked. CCND1 probe of red fluorescence hybridization with approximately 350 kb fragment on 11q13 was marked. Two red signals and two green signals of t (11;14) (q13;q32) appeared in the nucleus and hybridized with target fragments on 11q13 and 14q32. No yellow fusion signal or green and red signals appeared close to each other in t (11;14) (q13;32). FISH was conducted to determine whether the cells of red and green separated signals in the tumor area, which were greater than 15%, were positive. SPSS 11 .50 software was used for statistical analysis. The t-test was conducted, and t represents the differences between two sample averages. P<0.05 was considered statistically significant.
Statistical analysis

Results
Clinical features
Among the 112 cases of MCL, 91 were males and 21 were females. Their ages ranged from 27 to 78, with an average age of 58. Eighty-seven cases originated from the nodes; the most common symptom was extensive lymphadenopathy. Fourteen cases originated from the digestive tract, and they mostly manifested lymphoma polyposis. Eleven cases originated from the nasopharynx oropharynx, and 9 cases originated from the peripheral blood and bone marrow. The patients survived 3-90 months, and the average survival time was 37.6 months ( Table 1) .
Morphology
The 112 cases of MCL can be divided into mantle zone type (Figure 1) , namely, nodular and diffuse, according to Immunohistochemistry: cyclin D1 (+) (Envision, ×400); (C) Ki-67 expression was low (Envision, ×400).
organizational structure. They can also be divided into classic and variant types (such as blastoid variant and polymorphic variant) according to cytologic morphology. The proliferation of single lymphoid cell was visible and formed by a majority of small-to medium-sized cells. The nucleus showed a slightly irregular contour and was similar to the center cell, whereas the nucleolus was not evident. The tumors lack transformed cells (centroblast) or immunoblast cells; no proliferation center was observed. Hyaline degeneration of small vessels, which scattered in the absence of phagocytosis of epithelioid histiocytes, could be observed in some cases. One case of pleomorphic variant of MCL's tumor cells showed a medium or large size and was diffused, with pleomorphic nuclei. Nuclei were mostly rounding, but some were irregular, distorted, and recessed, with dispersed chromatin.
Nucleoli were visible, and high nuclear division rate was observed (Figure 2) . One case of blastoid variant of MCL's tumor cells was similar to lymphoblasts. It exhibited a medium size, and its nuclei were round, with sparse chromatin. Nucleolus was not evident, and high nuclear division rate was observed (Figure 3 ).
Immunohistochemistry
All of the 112 cases showed CD20, CD79a, and Pax5 positive, and CD3, CD10, CD21, CD23, and TdT negative. There were 106 cases with cyclin D1 positive, 6 cases with cyclin D1 negative, 104 cases with CD5 positive, 8 cases with CD5 negative, and 1 case with CD5 negative and CD10 positive (Figure 4 ). Ki-67 index was 5% to 90%. 
FISH results
The FISH results of 6 cases with negative cyclin D1 in MCL showed that the cell number of red and green separated signals was greater than 15%, indicating that chromosome translocation t (11;14) (q13;q32) existed. Among 8 cases of CD5 negative and cyclin D1 positive, 5 cases with the FISH results showed that the cell number of red and green separated signals was greater than 15%. This result implies that chromosome translocation t (11;14) (q13;q32) existed ( Figure 5) . The FISH results of 10 cases of CD5 positive and cyclin D1 positive in MCL showed that the cell number of red and green separated signals was greater than 15%, indicating the presence of chromosome translocation t (11;14) (q13;q32). Chromosome polyploidy appeared in 2 cases of them ( Figure 6 ). This disease is more common in white than black people. It is also common in Asian population, with the average onset age of 60. Moreover, this disease is found more in males than in females. Lymph nodes are the most frequently involved sites. The extranodal sites involved include the spleen, bone marrow, gastrointestine, and Waldeyer ring. It is usually manifested as lymphoma polyposis in the gastrointestinal tract. In this group, the incidence rate was 2.8%, and the ratio of male to female was 6:1-7:1. The average onset age was 56, and lymph nodes were the most common involved site, which is similar to that reported in literature 3 .
Statistical results
Differential diagnosis
At present, MCL is speculated to be derived from lymphocytes at the inner layer of the mantle zone without antigen stimulation. Its main morphological characteristic was the proliferation of single tumor cell. These cells were small to medium in size. Their nucleus was irregular and very similar to the center cell. Hyaline change in small blood vessels, which are scattered in epithelioid histiocytes (no phagocytosis), non-neoplastic transformation, and proliferation center were observed. The growth pattern can be divided into mantle zone, nodular, and diffuse types. It can also be divided into classic and variant (mother celllike, pleomorphic, small cell, fringe-like, etc.) according to cell morphology. Immunohistochemistry showed the presence of B cells labeled CD19, CD20, CD22, and CD79a positive. In almost all cases, T cell related antigen CD5 was positive. CD43 was often expressed, but other T cell antigens were usually negative. Few CD23 was expressed, and CD10, BCL-6, MUM-1 were occasionally expressed and frequently appeared in variant MCL. These observations make the diagnosis difficult, particularly when the morphology is not typical or the sample is not enough. Based on the aforementioned characteristics, tumors can be differentiated as follows:
(I) B small lymphocytic lymphoma (SLL 
Abnormal expression of MCL
MCL is not difficult to diagnose when typical morphology and typical immunophenotype are combined, but the group mark of some CD5 and cyclin D1 in MCL can be negative. Some studies 4, 5 shown that the expression of cyclin D1 in MCL were 50% to 70%, and 10% MCL with CD5 negative, and a few of MCL with CD10 positive. These phenomena are observed in some cases in this paper. Cyclin D1 negative may be related to tissue fixation, embedding, antibody sensitivity and specificity, and so on. Some studies found that some cyclin D1 negative and their t (11;14) translocation can be detected, or cyclin D2 and D3 are expressed. However, the expression of the latter is not unique because they can also be expressed in other lymphomas. Thus, morphology should be considered or other tests should be performed for some cyclin D1 negative to avoid missed diagnosis and misdiagnosis. In this study, 6 cases in cyclin D1 were negative, as detected by FISH, and their t (11;14) translocation was detected and diagnosed. If the diagnosis was solely based on morphology and combination with other tests was not conducted, MCL should only be considered in the diagnosis. In addition, identifying pleomorphic MCL of cyclin D1 negative and DLBCL of CD5 positive is difficult. Therefore, a more specific antibody labeling is necessary. Recent studies have found that the transcription factor SOX11, a family member of SOX, can affect the Rb-E2F pathway and then regulates the expression of cyclin D1. SOX11 regulates the expression in MCL with cyclin D1 negative or positive 6, 7 . It is obviously not expressed in mature lymphocytes; thus, it can be used as a specific biomarker of MCL. According to a recent report 8 , which is far less than classic MCL. Its mitotic rate is higher, and Ki-67 proliferation index is also higher. The Ki-67 proliferation index is the most important prognostic parameter of MCL in most studies. Previous studies also demonstrated that MCL mother cell-like or chromosome variant prone to polyploid and pleomorphic variant subtypes are related to high expression of cyclin D1 11 . Another study suggests that the prognosis of cyclin D1 negative is better 9 . In this paper, the Ki-67 index of the 2 cases of pleomorphic and blastoid variants was up to 90%, and the mitotic index ranged from 10 to 30/15 HPF. The disease rapidly progressed. Death within 3-6 months also shows that the prognoses of blastoid and polymorphic subtypes are poor. This study found the following interesting phenomenon: two CD5 and cyclin D1 positive in chromosome polyploidy were detected by FISH from the MCL cases during the CCND1 separation process. The two cases were diagnosed as late stage and involved the bone marrow. One patient died 46 d after diagnosis, and another patient is still under follow-up for 7 months after diagnosis. Confirmation is still needed whether a direct relationship exists between the polyploid in two cases and the progress in the late stage, and poor prognosis.
Summary
In summary, subdividing the subtype is necessary for MCL diagnosis to provide reference for the clinical treatment and prognosis. MCL is a type of special immunophenotypic B-cell lymphoma, which has distinct clinical presentation, morphology, and genetic phenotype. Its occurrence and developed mechanism need more in-depth study of molecular biology.
Results are expected to provide targets for specific treatment and provide a valuable biomarker for prognosis.
